Accessibility Menu
Tecan Group Ag logo

Tecan Group Ag(OTC) TCHBF

Current Price$225.65
Market Cap$2.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+679%
5 Year-55%
1 Year+9%
1 Month+10%
Tecan Group Ag last closing stock price
MetricPriceDate
Last closeUSD 225.652026-07-10
Tecan Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+13.96%USD 198.002026-06-25
1 month+9.81%USD 205.502026-06-05
3 month+47.79%USD 152.682026-03-12
Year to date+44.78%USD 155.862025-12-26
1 year+9.01%USD 206.992025-06-11
3 year-40.5%USD 379.222023-05-18
5 year-54.67%USD 497.842021-07-07
Since inception+678.81%USD 28.972005-01-31

Tecan Group Ag Financials at a Glance

Market Cap

$2.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 1.82B

Net Income (TTM)

-CHF 43.05M

EPS (TTM)

-$11.06

P/E Ratio

-20.41

Dividend

$1.93

Beta (Volatility)

-0.02 (Low)

Price

$225.65

Volume

1

Open

$225.65

Previous Close

$225.65

Daily Range

$225.65 - $225.65

52-Week Range

$155.25 - $225.65

Estimated Earnings Date

Aug 11, 2026

TCHBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tecan Group Ag

Tecan Group AG is a specialized provider of advanced laboratory instruments and comprehensive solutions, catering to pharmaceutical and biotechnology firms, academic research institutions, and diagnostic testing facilities. Established in 1980 and headquartered in Männedorf, Switzerland, Tecan operates globally, offering innovative products that enhance laboratory efficiency and accuracy.

Products and Services
  • Automated liquid handling systems for precise sample management
  • Next-generation sequencing reagents and immunoassays for advanced diagnostics
  • Comprehensive software solutions for laboratory automation and data analysis
Growth Outlook
  • Continued demand in life sciences and diagnostics sectors supports revenue growth
  • Expansion into emerging markets enhances global footprint and customer base
  • Investment in R&D drives innovation and product development, ensuring competitive edge
Financial Highlights
  • Recent quarterly revenue of CHF 443.2 million reflects strong market position
  • Trailing twelve months (TTM) gross profit margin stands at 35.2%, indicating operational efficiency
  • Net income for the latest quarter shows a recovery trend, with EPS at CHF -10.15
Tecan Group AG has established itself as a leader in the medical diagnostics and research industry, with a diverse product portfolio that meets the needs of various sectors. The company's commitment to innovation and quality positions it well for future growth, particularly as demand for laboratory automation and advanced diagnostics continues to rise. Recent financial performance indicates resilience, with a focus on improving profitability and expanding market reach. The strategic investments in research and development are expected to yield new products and solutions, further solidifying Tecan's competitive advantage in the marketplace.
AI Generated • Jul 11, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

3,244

CEO

Monica Del Carmen Manotas Urueta, MBA

Website

www.tecan.com

Headquarters

Männedorf, ZH 8708, CH

TCHBF Financials

Key Financial Metrics (TTM)

Gross Margin

35.22%

Operating Margin

5.07%

Net Income Margin

-12.54%

Return on Equity

-9.09%

Return on Capital

1.84%

Return on Assets

-6.52%

Earnings Yield

-4.90%

Dividend Yield

0.85%

Payout Ratio

-34.37%

Stock Overview

Market Cap

$2.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.53M

Volume

1

Avg. Volume

16.613

Financials (TTM)

Gross Profit

CHF 631.51M

Operating Income

CHF 120.36M

EBITDA

CHF 247.83M

Operating Cash Flow

CHF 286.52M

Capital Expenditure

-CHF 65.98M

Free Cash Flow

CHF 220.54M

Cash & ST Invst.

CHF 311.37M

Total Debt

CHF 218.33M

Tecan Group Ag Performance Analysis

Tecan Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 1,198,097,36615.7%
20232023-12-31CHF 1,195,553,226-0.2%
20242024-12-31CHF 1,060,874,766-11.3%
20252025-12-31CHF 1,062,606,4070.2%
Tecan Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-12.3%
Q42024-12-31-0.0%
Q22025-06-30-5.9%
Q42025-12-310.9%
Tecan Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 9.92-8.2%
20232023-12-31CHF 11.4615.6%
20242024-12-31CHF 6.01-47.6%
20252025-12-31CHF -10.52N/A
Tecan Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-71.5%
Q42024-12-31102.3%
Q22025-06-30-60.2%
Q42025-12-31-819.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CHF 443.22M

-16.8%

Gross Profit

CHF 151.64M

-18.4%

Gross Margin

34.21%

N/A

Market Cap

$2.83BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$920.07K

N/A

Employees

3,074

N/A

Net Income

-CHF 128.64M

-263.1%

EBITDA

CHF 51.32M

-40.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CHF 311.37M

-15.0%

Total Debt

CHF 218.33M

-30.9%

Accounts Receivable

CHF 165.56M

-14.7%

Inventory

CHF 212.57M

-16.4%

Long Term Debt

CHF 207.93M

-31.6%

Short Term Debt

CHF 21.08M

+72.2%

Return on Assets

-6.52%

N/A

Return on Invested Capital

3.18%

N/A

Free Cash Flow

CHF 47.76M

-25.3%

Operating Cash Flow

CHF 78.01M

-2.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLYAnsell Limited
$84.09+0.00%
ANSLFAnsell Limited
$21.64+0.00%
GNNDYGN Store Nord A/S
$41.74+0.07%
GGNDFGN Store Nord A/S
$13.39+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About TCHBF

What is the current price of Tecan Group Ag?

Tecan Group Ag is trading at $225.65 per share.

What is the 52-week range for Tecan Group Ag?

Over the past 52 weeks, Tecan Group Ag has traded between $155.25 and $225.65.

How much debt does Tecan Group Ag have?

As of the most recent reporting period, Tecan Group Ag reported total debt of CHF 275.93M.

How much cash does Tecan Group Ag have on hand?

Tecan Group Ag reported CHF 222.62M in cash and cash equivalents in its most recent financial results.

What is Tecan Group Ag’s dividend yield?

Tecan Group Ag currently has a dividend yield of 0.85%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services